Bcl2:Beclin 1 complex: multiple mechanisms regulating autophagy/apoptosis toggle switch

View/ Open
Issue Date
2012-02-28Author
Marquez, Rebecca T.
Xu, Liang
Publisher
e-Century Publishing
Type
Article
Article Version
Scholarly/refereed, publisher version
Published Version
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304572/Metadata
Show full item recordAbstract
Cancer cells have developed novel mechanisms for evading chemotherapy-induced apoptosis and autophagy-associated cell death pathways. Upon the discovery that chemotherapeutics could target these cell death pathways in a manner that was not mutually exclusive, new discoveries about the interrelationship between these two pathways are emerging. Key proteins originally thought to be “autophagy-related proteins” are now found to be involved in either inducing or inhibiting apoptosis. Similarly, apoptosis inhibiting proteins can also block autophagy-associated cell death. One example is the complex formed by the autophagy protein, Beclin 1, and anti-apoptotic protein Bcl-2, which leads to inhibition of autophagy-associated cell death. Researchers have been investigating additional mechanisms that form/disrupt this complex in order to better design chemotherapeutics. This review will highlight the role Bcl-2 and Beclin 1 play in cancer development and drug resistance, as well as the role the Bcl-2:Beclin 1 complex in the switch between autophagy and apoptosis.
Description
This is the published version, also available here: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304572/.
Collections
Citation
Marquez, Rebecca T. & Xu, Liang. "Bcl2:Beclin 1 complex: multiple mechanisms regulating autophagy/apoptosis toggle switch." (2011) Am J Cancer Res. 2012; 2(2): 214–221.
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.